DGAP-News

EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE - Seite 3

INTRODUCTION OF MID-TERM GOALS ALIGNED WITH ACTION PLAN 2025

• Introduction of mid-term goals until 2025 at Capital Markets Day on 20 April 2021, targeting revenues growth to > € 1,000 m, adjusted EBITDA of >= € 300 m and unpartnered research and development expenses of > € 100 m

Given current global insecurities surrounding the COVID-19 pandemic, a likely negative impact - though less pronounced than in 2020 - is already estimated within the guidance for revenues and adjusted EBITDA stated above.

Key figures of consolidated income statement & segment information
Evotec SE & subsidiaries - First quarter of 2021

In T€	EVT Execute4)	EVT Innovate5)	Intersegment Eliminations	Evotec Group Q1 2021	Evotec Group Q1 2020
External revenues1)	104,880	28,205	-	133,085	119,402
Intersegment revenues	32,033	-	(32,033)	-	-
Costs of revenue	(107,654)	(25,149)	30,397	(102,406)	(86,130)
Gross profit	29,259	3,056	(1,636)	30,679	33,272
Gross margin in %	21.4	10.8	-	23.1	27.9
R&D expenses2)	(2,001)	(18,095)	1,636	(18,460)	(15,056)
SG&A expenses	(17,033)	(4,161)	-	(21,194)	(17,254)
Other operating